WTAP and metabolic dysfunction-associated steatohepatitis: These data indicate that TNFα/PA/CDK9-mediated phosphorylation of WTAP may contribute to the reduction of nuclear WTAP levels in NASH livers, which may further contribute to the increased expression of CD36, IGFBP1 and CCL2, promoting NASH progression.